» Articles » PMID: 29868465

Exploring Applications of Radiomics in Magnetic Resonance Imaging of Head and Neck Cancer: A Systematic Review

Overview
Journal Front Oncol
Specialty Oncology
Date 2018 Jun 6
PMID 29868465
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Radiomics has been widely investigated for non-invasive acquisition of quantitative textural information from anatomic structures. While the vast majority of radiomic analysis is performed on images obtained from computed tomography, magnetic resonance imaging (MRI)-based radiomics has generated increased attention. In head and neck cancer (HNC), however, attempts to perform consistent investigations are sparse, and it is unclear whether the resulting textural features can be reproduced. To address this unmet need, we systematically reviewed the quality of existing MRI radiomics research in HNC.

Methods: Literature search was conducted in accordance with guidelines established by Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Electronic databases were examined from January 1990 through November 2017 for common radiomic keywords. Eligible completed studies were then scored using a standardized checklist that we developed from Enhancing the Quality and Transparency of Health Research guidelines for reporting machine-learning predictive model specifications and results in biomedical research, defined by Luo et al. (1). Descriptive statistics of checklist scores were populated, and a subgroup analysis of methodology items alone was conducted in comparison to overall scores.

Results: Sixteen completed studies and four ongoing trials were selected for inclusion. Of the completed studies, the nasopharynx was the most common site of study (37.5%). MRI modalities varied with only four of the completed studies (25%) extracting radiomic features from a single sequence. Study sample sizes ranged between 13 and 118 patients (median of 40), and final radiomic signatures ranged from 2 to 279 features. Analyzed endpoints included either segmentation or histopathological classification parameters (44%) or prognostic and predictive biomarkers (56%). Liu et al. (2) addressed the highest number of our checklist items (total score: 48), and a subgroup analysis of methodology checklist items alone did not demonstrate any difference in scoring trends between studies [Spearman's ρ = 0.94 ( < 0.0001)].

Conclusion: Although MRI radiomic applications demonstrate predictive potential in analyzing diverse HNC outcomes, methodological variances preclude accurate and collective interpretation of data.

Citing Articles

Magnetic Resonance Image Radiomic Reproducibility: The Impact of Preprocessing on Extracted Features from Gross and High-Risk Clinical Tumor Volumes in Cervical Cancer Patients before Brachytherapy.

Sadeghi M, Abdalvand N, Mahdavi S, Abdollahi H, Qasempour Y, Mohammadian F J Med Signals Sens. 2024; 14:23.

PMID: 39234589 PMC: 11373798. DOI: 10.4103/jmss.jmss_57_22.


The prognostic role of MRI-based radiomics in tongue carcinoma: a multicentric validation study.

Tagliabue M, Ruju F, Mossinelli C, Gaeta A, Raimondi S, Volpe S Radiol Med. 2024; 129(9):1369-1381.

PMID: 39096355 PMC: 11379741. DOI: 10.1007/s11547-024-01859-y.


Prediction of the Ki-67 expression level in head and neck squamous cell carcinoma with machine learning-based multiparametric MRI radiomics: a multicenter study.

Chen W, Lin G, Chen Y, Cheng F, Li X, Ding J BMC Cancer. 2024; 24(1):418.

PMID: 38580939 PMC: 10996101. DOI: 10.1186/s12885-024-12026-x.


Quantitative US Delta Radiomics to Predict Radiation Response in Individuals with Head and Neck Squamous Cell Carcinoma.

Osapoetra L, Dasgupta A, DiCenzo D, Fatima K, Quiaoit K, Saifuddin M Radiol Imaging Cancer. 2024; 6(2):e230029.

PMID: 38391311 PMC: 10988345. DOI: 10.1148/rycan.230029.


MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.

Corti A, De Cecco L, Cavalieri S, Lenoci D, Pistore F, Calareso G Biomark Res. 2023; 11(1):69.

PMID: 37455307 PMC: 10350277. DOI: 10.1186/s40364-023-00494-5.


References
1.
Chen L, Xu J, Bao J, Huang X, Hu X, Xia Y . Diffusion-weighted MRI in differentiating malignant from benign thyroid nodules: a meta-analysis. BMJ Open. 2016; 6(1):e008413. PMC: 4716219. DOI: 10.1136/bmjopen-2015-008413. View

2.
Gnep K, Fargeas A, Gutierrez-Carvajal R, Commandeur F, Mathieu R, Ospina J . Haralick textural features on T -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. J Magn Reson Imaging. 2016; 45(1):103-117. DOI: 10.1002/jmri.25335. View

3.
Ou D, Blanchard P, Rosellini S, Levy A, Nguyen F, Leijenaar R . Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status. Oral Oncol. 2017; 71:150-155. DOI: 10.1016/j.oraloncology.2017.06.015. View

4.
Parmar C, Grossmann P, Rietveld D, Rietbergen M, Lambin P, Aerts H . Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer. Front Oncol. 2015; 5:272. PMC: 4668290. DOI: 10.3389/fonc.2015.00272. View

5.
Zhao B, Tan Y, Tsai W, Qi J, Xie C, Lu L . Reproducibility of radiomics for deciphering tumor phenotype with imaging. Sci Rep. 2016; 6:23428. PMC: 4806325. DOI: 10.1038/srep23428. View